CiVi Biopharma Holdings
Bryn Mawr, US · Founded 2017 · Delaware corporation
Founders & leadership
CF
Christopher FuglesangNamed on SEC filing
AD
Aaron DavisNamed on SEC filing
HO
Henrik OerumNamed on SEC filing
SJ
Shalom JacobovitzNamed on SEC filing
Board
CN
Carole NuechterleinBoard director
Reported raises · per SEC filings
Form D private placements$76.5M disclosed across 2 rounds · 2018–2020
▶$27.5MraisedDec 2020 · 9 investors · BiotechnologyRule 506(b)
▶$27.5MraisedDec 2020 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew PietrasExecutive Officer
- Carole NuechterleinDirector
- Christopher FuglesangDirector
- Shalom JacobovitzExecutive Officer, Director
- Aaron DavisDirector
- Henrik OerumDirector
- Offering amount
- $27.5M
- Amount sold
- $27.5M
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$49MraisedMay 2018 · 6 investors · PharmaceuticalsRule 506(b)
▶$49MraisedMay 2018 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Christopher FuglesangDirector
- Aaron DavisDirector
- Henrik OerumExecutive Officer, Director
- Shalom JacobovitzExecutive Officer, Director
- Carole NuechterleinDirector
- Offering amount
- $49M
- Amount sold
- $49M
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has CiVi Biopharma Holdings raised?
- CiVi Biopharma Holdings has disclosed $76.5M raised across 2 rounds.
- Where is CiVi Biopharma Holdings headquartered?
- CiVi Biopharma Holdings is headquartered in Bryn Mawr, US.